Our policy positions are conveyed by our official statements, and contributions to public policy making consultation processes on global, regional and national levels. We propose high-impact, cost-effective and evidence-based solutions for preventing harm caused by alcohol and other drugs and in order to inspire transformative, sustainable change.
With almost 170 years worth of advocacy experience, Movendi International is the voice for comprehensive and sustainable policy solutions concerning current and complex health, development, Human Rights and economic issues. We work hand in hand with decision-makers and opinion leaders around the world.
Movendi Statements
148th Session of the WHO Executive Board – Virtual
The 148th session of the Executive Board of the World Health Organization is convened virtually due to the coronavirus pandemic.
January 19 – 26, 2021
Find all the documentation here.
Several agenda items relate to alcohol harm and policy solutions. Therefore, Movendi International made statements on the following agenda items.
Addressing agenda item 6: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
January 21, 2021
Official Movendi International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of Movendi International.
- Our statement, as delivered in a shorter, one-minute version (PDF)
Addressing agenda item 14.3: Mental health preparedness and response for the COVID-19 pandemic
January 20, 2021
Official Movendi International Statement by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of Movendi International.
- Our statement could not be delivered but was circulated to WHO Member States.
Addressing agenda item 16: Social determinants of health
January 22, 2021
Official Movendi International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of Movendi International.
- Our statement, as delivered in a shorter, one-minute version (PDF)
Resumed, virtual 73rd Session of the World Health Assembly
This year’s 73rd edition of the World Health Assembly resumed virtually on Monday, November 9, after a two-day emergency session in May earlier this year to deal with the coronavirus crisis
November, 09 – 13, 2020
Find all documentation here.
Key issues at the resumed WHA73
All statements by civil society in official relations with WHO can be found here, including Movendi International’s short statement (see agenda item 11, Committee A).
Addressing agenda item 11.2 Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues – Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
Official Movendi International Statement delivered on November 12, 2020 by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of Movendi International.
Three statement versions:
- As delivered (1 minute statement),
- As submitted to WHO (300 word statement), and
- Statement in full.
Civil Society Meeting: Financing for Development in the Era of COVID-19 and Beyond
Virtually held United Nations meeting
Monday, November 2, 2020, 9:00-11:30AM
The COVID-19 pandemic and the social and economic crisis it triggered are threatening the well-being of billions of people and risk derailing the global efforts to achieve the Sustainable Development Goals and address the growing climate emergency. In some parts of the world, the pandemic is fast turning into a humanitarian crisis, pushing entire populations into a state of acute food deprivation. International cooperation and solidarity among all stakeholders are imperatives to respond to the crisis induced by the pandemic and ensure an inclusive, sustainable and prosperous future.
On May 28, 2020, Canada, Jamaica and the Secretary-General convened a High-Level Event on “Financing for Development in the Era of COVID-19 and Beyond” to join forces with Heads of State and Government, international organizations, and other key partners to enable discussions of concrete financing solutions to the COVID-19 health and development emergency, guided by the roadmap set out in the 2030 Agenda for Sustainable Development. Six Member States-led Discussion Groups including civil society organizations produced a comprehensive and bold menu of policy options to survive and build back better from this crisis, which were presented to Finance Ministers at a High-Level Meeting on September 8, and to Heads of State and Government at a Leaders’ Meeting at September 29.
Building on this initiative, the meeting will provide an open and inclusive space for feedback on the outcomes of the above meeting and dialogue between civil society and the UN Secretary-General. In focusing on development financing, the meeting will put a human face to the challenges exposed and magnified by the pandemic, including the intersections between systemic economic reforms and the challenges and demands of peoples and their communities and climate action.
Addressing “Dialogue 2 – Menu of Options for Development Financing: Need to Focus on Strengthening Fiscal & Policy Space for Socio-Economic Transformation”
Movendi International addressed the meeting in the second dialogue on “Menu of Options for Development Financing: Need to Focus on Strengthening Fiscal & Policy Space for Socio-Economic Transformation”
Download the full statement here.
See the full meeting here and Maik’s statement at 02:03:32 hours of the session (UN WebTV).
Download the complete program of the meeting here.
73rd Session of the World Health Assembly
Virtual, de minimis meeting dedicated to the COVID-19 pandemic
May, 18, 2020
Find all documentation here.
All statements by civil society in official relations with WHO can be found here, including Movendi International’s short statement.
Addressing agenda item 3 WHO Director-General Speech on COVID-19 Pandemic
May 18, 2020
Official Movendi International Statement submitted for consideration by Kristina Sperkova, International President, on behalf of Movendi International.
WHA73 Statement by the WHO Civil Society Working Group on NCDs, including Movendi International President Kristina Sperkova
69th Session of the WHO Regional Committee for Europe
Copenhagen, Denmark
September 16 – 19, 2019
Find all documentation here.
IOGT International Written Statement by International President, Kristina Sperkova, on Agenda item 3: Matters arising from resolutions and decisions of the World Health Assembly and the Executive BoardEuropean Action Plan to Reduce the Harmful Use of Alcohol 2012 – 2020
Addressing agenda item 3 Matters arising from resolutions and decisions of the WHA and EB
September 19, 2019
Official IOGT International Statement (extra short) delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
Addressing agenda item 5(a) Health 2020: seven years on. Lessons learned from the implementation of the European health policy framework
September 17, 2019
Official IOGT International Statement (extra short) delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
Addressing agenda item 5(j) Progress report on the roadmap to implement the 2030 Agenda for Sustainable Development
September 19, 2019
Official IOGT International Statement (extra short) delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
72nd Session of the WHO Regional Committee for South-East Asia
New Delhi, India
September 2 – 6, 2019
Final all documentation here.
Addressing agenda item 7.2 Program Budget 2020-2021
September 3, 2019
Official IOGT International Statement delivered by Sampath De Seram, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 8.1 Annual report on monitoring progress on UHC and health-related SDGs
September 3, 2019
Official IOGT International Statement delivered by Sampath De Seram, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 9.6 Colombo Declaration on strengthening health systems to accelerate delivery of NCDs services at the PHC level
September 4, 2019
Official IOGT International Statement delivered by Sampath De Seram, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 10 Governing body matters
September 4, 2019
Official IOGT International Statement delivered by Sampath De Seram, Regional Representative to the UN, on behalf of IOGT International.
69th Session of the WHO Regional Committee Meeting for Africa
Brazzaville, Republic of the Congo
August 19 – 23, 2019
Find all the documentation here.
Addressing agenda item 7 13th General Program of Work, Results Framework
August 20, 2019
Official IOGT International Statement delivered by William Ntakuka, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 9 Progress Report on theImplementation of the Transformation Agenda
August 21, 2019
Official IOGT International Statement delivered by William Ntakuka, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 12 Framework for Provision of Essential Health Services Through strengthened District/ Local Health Systems to Support UHC in the Context of the SDGs
August 22, 2019
Official IOGT International Statement delivered by William Ntakuka, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 14 Accelerating the Response to NCDs in Line with the Political Declaration of the UNGA HLM on NCDs
August 22, 2019
Official IOGT International Statement delivered by William Ntakuka, Regional Representative to the UN, on behalf of IOGT International.
Addressing agenda item 15.3 Progress Report on Implementation ofRegional Strategy for Cancer Prevention and control
August 23, 2019
Official IOGT International Statement delivered by William Ntakuka, Regional Representative to the UN, on behalf of IOGT International.
72nd Session of the World Health Assembly
UN Palais des Nations, Geneva, Switzerland
May 20 – 28, 2019
Find the WHA72 web-streaming and photos: here
Find the documentation: here
All statements delivered by Member States: here
All statements delivered by Non-State Actors (including IOGT International): here
Addressing agenda item 11.1 Proposed Program Budget
May 21, 2019
Official IOGT International Statement delivered by Kristina Sperkova, International President, on behalf of IOGT International.
Relevant documents (with our comments) discussed: A72/4 (pdf) and A72/5 (pdf)
Addressing agenda item 11.4 Implementation of the 2030 Agenda For Sustainable Development
May 21, 2019
Official IOGT International Statement – not verbally delivered
Relevant document (with our comments) discussed: A72/11 (pdf)
Addressing agenda item 11.5 Universal Health Coverage – Primary Health Care for UHC
May 22, 2019
Official IOGT International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
Relevant document (with our comments) discussed: A72/12 (pdf)
Addressing agenda item 11.6 Health, environment and climate change
May 23, 2019
Official IOGT International Statement delivered by Toyyib Abdulkareem, on behalf of IOGT International, supported by the NCD Alliance, UICC and Vital Strategies.
Addressing agenda item 11.8 Follow-up UNGA HLM Prevention and control of Noncommunicable diseases
May 24, 2019
Official IOGT International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
Relevant document (with our comments) discussed: A72/19 (pdf)
Addressing agenda item 12.7 Eleventh revision of the International Classification of Disease
May 25, 2019
Official IOGT International Statement delivered by Kristina Sperkova, International President, on behalf of IOGT International.
Addressing agenda item 12.8 Global Strategy on Women’s, Children’s and Adolescents’ Health
May 25, 2019
Official IOGT International Statement delivered by Kristina Sperkova, International President, on behalf of IOGT International, supported by the International Federation of Medical Students’ Associations.
Relevant document (with our comments) discussed: A72/30 (pdf)
Interactive Multi-Stakeholder Hearing to prepare for the High-level meeting on Universal Health Coverage
UN General Assembly Hall, New York, USA, April 29, 2019
Addressing Session 1: UHC as a driver for inclusive development and prosperity
Official IOGT International statement delivered by Robert Pezzolesi, Representative to the UN, IOGT International
Live UN webcast from the multi-stakeholder hearing
//www.un.org/webcast/1362235914001/B1J3DDQJf_default/index.html?videoId=6031167498001
Our statement commences at ca. 2:38:24 hours.
Find the concept note and program of the multi-stakeholder hearing here.
62nd Commission on Narcotic Drugs
Vienna, Austria, March 14 – 22, 2019
Addressing the Ministerial Segment
Vienna, Austria, March 14, 2019
“Taking stock of the implementation of the commitments made to jointly address and counter the world drug problem, in particular in light of the 2019 target date”
Official statement delivered by Kristina Sperkova, International President, on behalf of IOGT International.
Addressing plenary session on Agenda item 10a)
10. Implementation of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem: (a) Demand reduction and related measures;
Official statement delivered by Cecilie Widnes, Member of the International Board, IOGT International
144th Session of the WHO Executive Board
Geneva, Switzerland, January 24 – February 1, 2019
EB 144 documentation and web streaming: here
All statements delivered by Member States: here
All statements delivered by Non-State Actors (including IOGT International): here
Addressing agenda item 5.1 Proposed Program Budget
January 25, 2019
Official IOGT International Statement delivered by Kristina Sperkova, International President, on behalf of IOGT International and supported by the NCD Alliance and Vital Strategies.
Relevant document (with our comments) discussed: EB144/5 (pdf)
Addressing agenda item 5.4 Implementation of the 2030 Agenda For Sustainable Development
January 26, 2019
Official IOGT International Statement delivered by Kristina Sperkova, International President, on behalf of IOGT International and supported by the NCD Alliance and Vital Strategies.
Relevant document (with our comments) discussed: EB144/11 Rev.1 (pdf)
Addressing agenda item 5.8.2 Follow-up UNGA HLM Prevention and control of Noncommunicable diseases
January 30, 2019
Official IOGT International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
Relevant document (with our comments) discussed: EB144/20 (pdf)
Addressing agenda item 5.9 Eleventh revision of the International Classification of Disease
January 30, 2019
Official IOGT International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International.
Addressing agenda item 7.1 WHO Reform Process EB144/34
January 31, 2019
Official IOGT International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International, supported by Medicus Mundi International and Wemos.
Addressing agenda item 7.3 Engagement with Non-State Actors
January 31, 2019
Official IOGT International Statement delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International, supported by the NCD Alliance, World Obesity Federation, NCD Child, and the World Cancer Research Fund International
43rd UN AIDS Program Coordinating Board
Geneva, Switzerland, December 11 – 13, 2018
The 43rd meeting of the UN AIDS Program Coordinating Board (PCB43) took place in Geneva, Switzerland, at the UN AIDS headquarters. IOGT International submitted two and delivered on statement, during the “Thematic segment Mental Health and HIV/AIDS – promoting human rights, an integrated and person-centred approach to improving ART adherence, well-being and quality of life”.
IOGT International Official Statement UNAIDS/ PCB (43)/ 18.28
The statement was submitted by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International on December 12, 2018.
IOGT International Official Statement UNAIDS/ PCB (43)/ 12 Thematic segment
The statement was delivered by Maik Dünnbier, Director of Strategy and Advocacy, on behalf of IOGT International on December 13, 2018.
68th Regional Committee Meeting WHO EUROPE
Rome, Italy, September 17 – 20, 2018
The 68th session of the Regional Committee of the World Health Organization Office for Europe convened in Rome, Italy and IOGT International submitted the following policy statements:
- Written Statement by Kristina Sperkova on behalf of IOGT International, submitted September 5, 2018
- Oral statement by Esbjörn Hörnberg on behalf of IOGT International
71st Regional Committee Meeting WHO SEARO
New Delhi, India, September 3 – 7, 2018
The Seventy-first Session of the Regional Committee of the World Health Organization Regional Office For South-East Asia convened in Hotel Taj Mahal, New Delhi, India.
- Side Event on Preparation for the UN General Assembly High-Level Meetings on Tuberculosis and NCD prevention and control, IOGT International statement, by Mr Suneel Vatsyayan
- Agenda item 8.5: Annual report on monitoring progress on UHC and health-related SDGs, IOGT International statement, by Mr Suneel Vatsyayan
World Congress Declaration
Sigtuna, Sweden, August 10, 2018
The Delegates of the 69th IOGT International World Congress “Future Made Here” call for the adoption of a Framework Convention on Alcohol Control and for governments to make alcohol policy solutions the priority they should be in order to achieve development for all.
Official Statements at the United Nations Interactive Hearing on NCDs
United Nations Headquarters, New York, July 5, 2018
IOGT International issued three statements, one for each of the three first panel discussions, during the Interactive Hearing. The statement for the second panel was actually delivered, while the other two were submitted to a dedicated WHO website.
#1 IOGT International statement for Panel 1: Scaling up action for the prevention and control of NCDs
#2 IOGT International statement for Panel 2: Financing for the prevention and control of NCDs, statement delivered by Robert Pezzolesi, IOGT’s special representative to the UN//www.un.org/webcast/1362235914001/B1J3DDQJf_default/index.html?videoId=5805861258001
The Interventions starts at ca. 2:42:09 of the broadcast.
#3 IOGT International statement for Panel 3: Promotion of multisectoral partnerships for the prevention and control of Non-Communicable Diseases
In accordance with paragraph 7 of UN resolution A/RES/72/274, the President of the UN General Assembly, with the support of WHO, organized and presided over an interactive hearing which took place on July 5, 2018 in New York as part of the preparatory process for the third High-Level Meeting of the UN General Assembly on the Prevention and Control of NCDs.
Official Statement on United Nations International Day Against Drug Abuse and Illicit Trafficking and Launch of World Drug Report 2018
Vienna, Austria, June 26, 2018
IOGT International statement on the occasion of the UN International Day against Drug Abuse and Illicit Trafficking, commemorated at the United Nations in Vienna, and the launch of the 2018 edition of the World Drug report, delivered by Executive Director Esbjörn Hörnberg.
#1 Official Statement WHA 71
UN Palais des Nations, Geneva, Switzerland, May 22, 2018
IOGT International statement at the 71st session of the World Health Assembly, Agenda item 11.1, Draft 13th General Program of Work 2019-2023, delivered by International President Kristina Sperkova (shorter version delivered)*.
#2 Official Statement at WHA71
UN Palais des Nations, Geneva, Switzerland, May 24, 2018
IOGT International statement at the 71st session of the World Health Assembly, Agenda item 11.7, Preparation for the third High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases, delivered by International President Kristina Sperkova (shorter version delivered)*.
#3 Official Statement at WHA71
UN Palais des Nations, Geneva, Switzerland
IOGT International statement at the 71st session of the World Health Assembly, Agenda item 11.8, Preparation for a high-level meeting of the General Assembly on ending tuberculosis, delivered by Director of Strategy and Advocacy Maik Dünnbier (shorter version delivered)*.
#4 Official Statement at WHA71
UN Palais des Nations, Geneva, Switzerland
IOGT International statement at the 71st session of the World Health Assembly, Agenda item 20.3 D. Public health dimension of the world drug problem (decision WHA70(18) (2017)), submitted to Committee B for consideration*.
*All statements (including all IOGT International statements) delivered by Non-State Actors at the WHA71 can be found here.
Oral Statement at CND61
United Nations, Vienna, Austria, March 12 – 16, 2018
IOGT International Statement to the 61st Session of the Commission on Narcotic Drugs, delivered by Director of Strategy and Advocacy Maik Dünnbier.
Written Statement at CND61
Vienna, Austria, March 12 – 16, 2018
IOGT International Statement to the 61st Session of the Commission on Narcotic Drugs, delivered by International President Kristina Sperkova.
Written Statement at CSocD56
Stockholm, Sweden, November 19, 2017
IOGT International statement to the 56th Session of the Commission for Social Development (CSocD56) with the priority theme “Strategies for eradicating poverty to achieve sustainable development for all”.
Ministerial Panel Presentation at 1st WHO Global Ministerial Conference on Ending TB
Moscow, Russian Federation, November 17, 2017
IOGT International was invited by the World Health Organization to participate in and contribute to the “Ministerial Parallel Panel: Synergies across the responses to TB and NCDs” at the “FIRST WHO GLOBAL MINISTERIAL CONFERENCE ENDING TB IN THE SUSTAINABLE DEVELOPMENT ERA: A MULTISECTORAL RESPONSE” between November 16-17, 2017.
IOGT International was represented by Director of Strategy and Advocacy Maik Dünnbier.
Civil Society Dialogue with EU Trade Commissioner Malmström on Trade and Sustainable Development
Brussels, Belgium, October 6, 2017
This meeting is part of an ongoing process of Civil Society Dialogue on EU trade policy. Commissioner Malmström presented current developments and exchange views with civil society organisations on Trade and Sustainable Development. The Commission is undertaking comprehensive discussions with the Council, EP and stakeholders with a view to improve implementation of Trade and Sustainable Development (TSD) chapters in the EU’s free trade agreements.
Joint NGO statement on health sustainability in trade and investment agreements,
together with All-Ukrainian Network PLWH, Association of European Cancer Leagues (ECL), European AIDS Treatment Group (EATG), European Alcohol Policy Alliance (EUROCARE), European Heart Network (EHN), European Public Health Alliance (EPHA), European Respiratory Society (ERS), Health Action International Europe (HAI Europe), IOGT International, IOGT-NTO, International Federation of Anthroposophic Medical Associations (IVAA), International Federation of Medical Students’ Associations (IFMSA), Smoke Free Partnership (SFP).
67 WHO Regional Committee for Europe Statements
Budapest, Hungary, September 11 to 14, 2017
- Written statement by Kristina Sperkova on behalf of IOGT International
August 31, 2017 - Oral statement by Maik Dünnbier on behalf of IOGT International
September 6, 2017
- Joint Statement by IFMSA, EPHA, Studiorum, and IOGT International
September 14, 2017 (delivered by IFMSA)
Joint Statement at 70th WHO Regional Committee for South-East Asia 2017
Maldives, September 6 to 10, 2017
Joint statement together with the NCD Alliance, Healthy India Alliance, Global Alcohol Policy Alliance, and IOGT International.
Official Statement at ECOSOC High-Level Segment 2017
United Nations, New York, United States, July 20, 2017
IOGT International Statement to the 2017 High-Level Segment of the UN Economic and Social Council, delivered by International President Kristina Sperkova.//www.un.org/webcast/1362235914001/B1J3DDQJf_default/index.html?videoId=5514595251001
*Forward to minute 54:38 to see and hear the statement
Written Statement at ECOSOC High-Level Segment 2017
Stockholm, Sweden, April 21, 2017
IOGT International Statement to the 2017 High-Level Segment of the UN Economic and Social Council.
Official Statement at 1st WHO FADAB
World Health Organization, Geneva, Switzerland, June, 26, 2017
IOGT International Statement to the High-level segment of the 1st World Health Organization Forum on Alcohol, Drugs, and Addictive Behaviors, delivered by International President Kristina Sperkova.
Official Statement at CND60
United Nations, Vienna, Austria, March 17, 2017
IOGT International Statement to the 60th Session of the Commission on Narcotic Drugs, delivered by International Vice President Pubudu Sumanasekara.
Written Statement at CSW61
New York, United States, March 13, 2017
CSW61 Priority Theme:
Women’s economic empowerment in the changing world of work
Official Statement at CND59
United Nations, Vienna, Austria, March 15, 2016
IOGT International Statement to the 59th Session of the Commission on Narcotic Drugs, Special Segment on UNGASS 2016, delivered by International President Kristina Sperkova.
Written Statement at CSW60
New York, United States, March 14, 2016
IOGT International Written Statement to 60th Session of the Commission on the Status of Women
CSW60 Priority Theme:
Women’s empowerment and its link to sustainable development
Written Statement at CSW59
New York, United States, March 18, 2015
IOGT International Written Statement to 59th Session of the Commission on the Status of Women
CSW59 Priority Theme:
The review of progress made in the implementation of the Beijing Declaration and Platform for Action, 20 years after its adoption at the Fourth World Conference on Women in 1995
Official Statement at CND58
United Nations, Vienna, Austria, March 11, 2015
IOGT International Oral Statement on Drugs and Human Rights, Youth, Women, Children and Communities: “Five Points: Illicit Drugs And Human Rights Issues”
Oral Statement at CND58
United Nations, Vienna, Austria, March 9, 2015
IOGT International Statement at 58th Session of the Commission on Narcotic Drugs: “6 Points Of Expectations For UNGASS 2016”
Oral Statement at CSW57, with endorsements of international decision-makers
United Nations, New York, United States, March 15, 2013
IOGT International statement at 57th Session of UN Commission on the Status of Women
Consultation Contributions
2018 consultation contributions
- May 16, 2018
IOGT International submission to
the WHO Independent High-level Commission hosted web-based consultation (May 10-16, 2018) on a preliminary draft report dated 1 May 2018.
2017 consultation contributions
- November 14, 2017
IOGT International contribution to
WHO Consultation on the 13th General Program of Work 2019 – 2023 (2nd round of online consultation), in preparation of the WHO Special Session of the Executive Board (EBSS4).
- October 12, 2017
IOGT International submission to
WHO Consultation on 13th General Program of Work 2019 – 2023
- August 25, 2017
IOGT International contribution to
Development of an outcome document for the WHO Global Conference on NCDs – Montevideo Roadmap 2018-2030 on NCDs as a Sustainable Development Priority
- May 02, 2017
IOGT International submission to
European Commission consultation on Modernizing and Simplifying the Common Agricultural Policy (CAP)
- May 01, 2017
IOGT International contribution to
World Health Organization Discussion Paper Draft (Version February 14, 2017) on Developing Voluntary Global Performance Targets for Road Safety Risk Factors and Service Delivery Mechanisms
- April 17, 2017
IOGT International submission to
European Commission consultation on Inception Impact Assessment: General Agreements for Excise Duty – Harmonization and Simplification
2016 consultation contributions
- December 21, 2016
IOGT International submission to
European Commission Consultation on the Draft Final Report on the TTIP Sustainability Impact Assessment (SIA)
- August 31, 2016
IOGT International response to
WHO Discussion Paper (July 25, 2016) Updating Appendix 3 of the WHO NCDs Global Action Plan
2015 consultation contributions
- November 27, 2015
IOGT International submission to
European Commission Consultation on Review of existing legislation on the structures of excise duties on alcohol and alcoholic beverages
- September 30, 2015
IOGT International contribution to
European Commission Consultation on Directive 2010/13/EU on audiovisual media services (AVMSD) A media framework for the 21st century
- August 28, 2015
IOGT International contribution to
UN AIDS Strategy 2016 – 2021 Official Consultation Contribution
- May 05, 2015
Every Woman Every Child – Global Strategy for Women’s, Children’s and Adolescents’ Health – ZERO DRAFT FOR CONSULTATION
- April 26, 2015
IOGT International response to
“Stakeholder feedback on the indicators for the SDGs in the Post-2015 Development Agenda”
- November, 2014
Reinvigorating independent evidence – an IOGT International response to IARD consultation contribution on
WHO Discussion paper from October 29, 2014: ”SUBMISSION ON BEHALF OF THE INTERNATIONAL ALLIANCE FOR RESPONSIBLE DRINKING (IARD) ON WHO DISCUSSION PAPER ‘FRAMEWORK FOR COUNTRY ACTION ACROSS SECTORS FOR HEALTH AND HEALTH EQUALITY’”
2014 consultation contributions
- July 13, 2014
IOGT International contribution to
European Commission “Online public consultation on investment protection and investor-to-state dispute settlement (ISDS) in the Transatlantic Trade and Investment Partnership Agreement (TTIP)”
2013 consultation contributions
- October 30, 2013
IOGT International Response to
“First WHO Discussion Paper (Version dated July 23, 2013) Draft Terms of Reference for a Global Coordination Mechanism for the Prevention and Control of NCDs”
- May 10, 2013
IOGT International contribution to
“Proposed Transatlantic Trade and Investment Agreement“ a public consultation by the US government on the Proposed TTIP
- March 29, 2013
IOGT International response to
4th round of informal consultations concerning the WHO Global Action Plan for Prevention and Control of NCDs 2013-2020
“Updated Revised Draft Global Action Plan for Prevention and Control of Non-Communicable Diseases 2013-2020”
- March 15, 2013
IOGT International Contribution to
Swedish Chamber of Commerce Consultation on EU-Thailand Free Trade Agreement Negotiations
- March 15, 2013
IOGT International response to
On-going, informal consultations concerning the Global Action Plan for Prevention and Control of Non-Communicable Diseases 2013-2020
- March 10, 2013
IOGT International contribution to
Discussion of the WHO second consultation round concerning the monitoring framework for NCDs
“Revised Draft Global Action Plan for Prevention and Control of Non-Communicable Diseases 2013-2020“
2012 consultation contributions
- October 16, 2012
IOGT International contribution to
Discussion of WHO “Development of an updated Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases 2013 – 2020″
- September 07, 2012
IOGT International reply to
World Health Organisation, Consultation on “Monitoring Framework and Targets for the Prevention and Control of Non-Communicable Diseases”
“Global Action Plan 2013 – 2020 for Prevention and Control of NCDs”
- April 16, 2012
IOGT International reply to
World Health Organisation, Consultation on “Options for Strengthening and Facilitating Multisectoral Action for the Prevention and Control of Non-Communicable Diseases through Partnership”
“Monitoring Framework and Targets for the Prevention and Control of NCDs“
- April 03, 2012
IOGT International reply to
European Commission Directorate-General Justice Consultation on the Communication “Towards a Stronger European Response to Drugs”
- January, 2012
“Towards a Stronger European Response to Drugs”
